Baxter Healthcare Corporation
⚠️ High Risk
FEI: 1417572 • Deerfield, IL • UNITED STATES
FEI Number
1417572
Location
Deerfield, IL
Country
UNITED STATESAddress
1 Baxter Pkwy, , Deerfield, IL, United States
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NEW VET DR
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 1/28/2025 | 55RY55SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
| 12/19/2024 | 65RDK17RINGER'S INJECTION, LACTATED (REPLENISHER) | 179AGR RX | Division of Northern Border Imports (DNBI) |
| 12/5/2024 | 65RDK19SODIUM CHLORIDE (REPLENISHER) | 179AGR RX | Division of Northern Border Imports (DNBI) |
| 6/15/2022 | 55RP55SODIUM CHLORIDE (PHARMACEUTIC NECESSITY - TONICITY AGENT) | Division of Northern Border Imports (DNBI) | |
| 9/11/2012 | 61TCK17PROMETHAZINE HCL (ANTI-EMETIC/NAUSEANT) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 9/11/2012 | 61TCK17PROMETHAZINE HCL (ANTI-EMETIC/NAUSEANT) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 4/6/2012 | 61XDK18DIPHENHYDRAMINE HCL (ANTI-HISTAMINIC) | Division of Southeast Imports (DSEI) | |
| 3/9/2012 | 80MRZACCESSORIES, PUMP, INFUSION | New Orleans District Office (NOL-DO) | |
| 12/6/2011 | 68XCA10SMALL ANIMAL DEVICE/DIAG PROD FOR ANIMAL | 72NEW VET DR | New Orleans District Office (NOL-DO) |
| 12/6/2011 | 65QOP22METHOCARBAMOL (RELAXANT) | 72NEW VET DR | New Orleans District Office (NOL-DO) |
| 8/24/2011 | 73NVPHOLDING CHAMBERS, DRUG DELIVERY DIRECT PATIENT INTERFACE | 118NOT LISTED | New England District Office (NWE-DO) |
| 2/6/2007 | 61LAP22ANTI-COAGULANT HEPARIN SOL | 179AGR RX | New Orleans District Office (NOL-DO) |
| 2/6/2007 | 61QAP03DESMOPRESSIN ACETATE (ANTI-DIURETIC) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 2/1/2007 | 66VCP99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/18/2006 | 65RDY99REPLENISHER N.E.C. | 75UNAPPROVED | New York District Office (NYK-DO) |
| 3/10/2006 | 65RCK14POTASSIUM CHLORIDE (REPLENISHER) | Cincinnati District Office (CIN-DO) | |
| 3/10/2006 | 65RCK14POTASSIUM CHLORIDE (REPLENISHER) | Cincinnati District Office (CIN-DO) | |
| 3/10/2006 | 65RCK14POTASSIUM CHLORIDE (REPLENISHER) | 179AGR RX | Cincinnati District Office (CIN-DO) |
| 3/9/2006 | 65RCK14POTASSIUM CHLORIDE (REPLENISHER) | 179AGR RX | Cincinnati District Office (CIN-DO) |
| 3/9/2006 | 65RCK14POTASSIUM CHLORIDE (REPLENISHER) | 179AGR RX | Cincinnati District Office (CIN-DO) |
| 6/6/2003 | 63ECP19AMIODARONE HYDROCHLORIDE (CARDIAC DEPRESSANT (ANTI-ARRHYTHMIC)) | Southwest Import District Office (SWI-DO) |
Frequently Asked Questions
What is Baxter Healthcare Corporation's FDA import refusal history?
Baxter Healthcare Corporation (FEI: 1417572) has 21 FDA import refusal record(s) in our database, spanning from 6/6/2003 to 1/28/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Baxter Healthcare Corporation's FEI number is 1417572.
What types of violations has Baxter Healthcare Corporation received?
Baxter Healthcare Corporation has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Baxter Healthcare Corporation come from?
All FDA import refusal data for Baxter Healthcare Corporation is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.